$1.1 million on two deals announced is phenomenal in my opinion. All of this revenue is to close before end of year!!!
Not a bad start for 2008. If Sequiam continues with the +$500-$750K from previous quarters from sales to existing resellers Sequiam should close out the year in a very respectable fashion. This should equate in my estimate of at least $2 million in revenue in 4th quarter and over $4 million in sales for FY 2008.
I really feel this company is turning the corner and have a feel of relief due to the fact no indications of toxic financing/filings have been recorded or mentioned over the past couple of months. All the while the company has needed cash to deliver on this growth they haven't financed these deals in an inappropriate manner.
I really do expect the outstanding share count to increase if the share price increases due to the warrants exercisable above .21. Then again if the warrants do convert Sequiam will receive a cash infusion on every warrant that converts based on the .21 strike price.
Having said that, I do believe the anticipated supply and possible dilution concerns from the .21 warrants will only be a temporary concern based on the fundamentals of the company going forward and more indicative of the present which we should understand in the coming weeks.
I also feel if some want to discuss the potentially dilutive share structure on Sequiam that we also bring forward the potential revenue stream that would support the share structure if all warrants above the current price converted.
I understand from reading a few comments on this board this has been made a concern about the fully dilutive amount of shares would be 168 million if all warrants exercised which is higher than the current outstanding of currently 93 million.
Again, Revenue projections for next year if the fully dilutive comes into play should be around $36 million. Based on this I feel the market cap of this company is extremely low concerning comparable companies involved in the biometric industry. If some want to discuss the fully dilutive share count in the future then I would request they discuss this in comparison to the $36 million revenue stream which would be appropriate and necessary in order to exercise the warrants.
Again, I'm throwing out a revenue estimate of $36 million for full year 2008. My potential revenue stream of this company could become a very conservative revenue estimate if Sequiam executes on the opportunites they have on the table.
Black and Decker, Fujitsu, and any speculation on Microsoft?
At .12 I feel this company has more upside than downside at this point.
I also agree, due to the the recent association of Jake Smith/Intel, Bob Aoki/Microsoft, Chris Barrow/3-Com, and Robert Allen Barclays/Wells Fargo/ Frost and Sullivan was no coincidence. These individuals have credible backgrounds and all to jump on the wagon within a very short time frame sends a loud message to me while no one is really looking at this company besides a select few of this primarily on this message board.
Basically no exposure or hype of this company is in the stock price. This should not be the case in 2008.
Very happy with my investment with Sequiam and I will be adding in the coming weeks as well as telling others..
Enjoy the Holidays!
News 
Market Data 
Discover 
AI
